Although the molecular mechanisms by which TMED3 promotes chordoma progression are not fully understood, evidence shows that TMED3 plays these functions through activating PI3K/AKT signaling and inhibiting apoptosis and MAPK9/JNK2 signaling pathways [57]. The gene discussed is MAPK9; the disease is chordoma.